Paul Evans of Velocity Clinical Research joins Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, to discuss best practices for sites making the shift toward decentralized trials. He shares how his own organization was able to pivot so quickly when the pandemic hit, why it’s too early to make the call on whether virtual will be cost saving, and how he pictures the future of his 12 (and counting) sites.